Soejima, Y.; Takeuchi, M.; Akashi, T.; Sawabe, M.; Fukusato, T.
β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. Int. J. Mol. Sci. 2018, 19, 1004.
https://doi.org/10.3390/ijms19041004
AMA Style
Soejima Y, Takeuchi M, Akashi T, Sawabe M, Fukusato T.
β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences. 2018; 19(4):1004.
https://doi.org/10.3390/ijms19041004
Chicago/Turabian Style
Soejima, Yurie, Miho Takeuchi, Takumi Akashi, Motoji Sawabe, and Toshio Fukusato.
2018. "β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma" International Journal of Molecular Sciences 19, no. 4: 1004.
https://doi.org/10.3390/ijms19041004
APA Style
Soejima, Y., Takeuchi, M., Akashi, T., Sawabe, M., & Fukusato, T.
(2018). β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences, 19(4), 1004.
https://doi.org/10.3390/ijms19041004